Cargando…

Elevated Lipoprotein(a) and Cerebral Venous Sinus Thrombosis in COVID-19

Detalles Bibliográficos
Autores principales:	Vuorio, Alpo, Kaste, Markku, Kovanen, Petri T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108374/ https://www.ncbi.nlm.nih.gov/pubmed/34039523 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105865

Ejemplares similares

Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
por: Vuorio, Alpo, et al.
Publicado: (2021)

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”
por: Vuorio, Alpo, et al.
Publicado: (2021)

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2020)

Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment
por: Vuorio, Alpo, et al.
Publicado: (2021)

Drug-drug interaction with oral antivirals for the early treatment of COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2023)

Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
por: Kovanen, Petri T., et al.
Publicado: (2021)

Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment?
por: Vuorio, Alpo, et al.
Publicado: (2021)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten
por: Vuorio, Alpo, et al.
Publicado: (2022)

Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
por: Vuorio, Alpo, et al.
Publicado: (2021)

Impact of cerebral venous sinus thrombosis associated with COVID-19
por: Hinduja, Archana, et al.
Publicado: (2021)

Malignant Cerebral Venous Sinus Thrombosis in Polycythemia
por: Mahale, Rohan, et al.
Publicado: (2015)

Changes in trend of cerebral venous sinus thrombosis
por: Shakibajahromi, Banafsheh, et al.
Publicado: (2019)

Cerebral venous sinus thrombosis: Diagnostic dilemma
por: Venugopal, Nataraja P
Publicado: (2022)

Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation
por: Vuorio, Alpo, et al.
Publicado: (2021)

Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era
por: Shakibajahromi, Banafsheh, et al.
Publicado: (2020)

Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy
por: Vuorio, Alpo, et al.
Publicado: (2022)

Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing
por: Vuorio, Alpo, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis with nontraumatic subdural hematoma
por: Sahoo, Ranjan Kumar, et al.
Publicado: (2015)

Deep cerebral venous sinus thrombosis with transient antiphospholipid antibodies in COVID-19 disease
por: Loos, C. M. J., et al.
Publicado: (2021)

Bilateral chorea as a manifestation of cerebral venous sinus thrombosis associated with COVID-19()
por: Revert Barberà, A., et al.
Publicado: (2022)

Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment
por: Vuorio, Alpo, et al.
Publicado: (2023)

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters
por: Vuorio, Alpo, et al.
Publicado: (2018)

SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease
por: Kovanen, Petri T., et al.
Publicado: (2023)

Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis
por: Gil-Díaz, Aída, et al.
Publicado: (2022)

Direct Mechanical Thrombectomy with Thromboaspiration in Cerebral Venous Sinus Thrombosis
por: Bohra, Vikram, et al.
Publicado: (2017)

Styloidogenic jugular venous compression syndrome as a source of cerebral venous sinus thrombosis
por: Woo, Ho Geol, et al.
Publicado: (2022)

Cerebral Venous Sinus Thrombosis Presenting as Ménière's-Disease-Mimicking Symptoms
por: Yoon, Sungjoon, et al.
Publicado: (2021)

Cerebral venous sinus thrombosis: Role of extra cranial collateral circulation
por: Sharma, Chandramohan B., et al.
Publicado: (2015)

Treatment of cerebral venous sinus thrombosis with subdural hematoma and subarachnoid hemorrhage
por: Khatib, Khalid Ismail, et al.
Publicado: (2016)

Venous cerebral thrombosis in COVID-19 patient
por: Garaci, Francesco, et al.
Publicado: (2020)

Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge
por: Vuorio, Alpo, et al.
Publicado: (2021)

Cerebral Venous Thrombosis following COVID-19 Vaccination
por: Kow, Chia Siang, et al.
Publicado: (2021)

Cerebral Venous Thrombosis Associated with COVID-19 Infection
por: Yasiev, Islam Y., et al.
Publicado: (2021)

Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination
por: Cheng, Newman
Publicado: (2021)

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2014)

SARS-CoV-2 infection: possible underdiagnosis of cerebral venous sinus thrombosis()
por: Almarcha-Menargues, M.L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4lsla9alfj75ggf17dmt5h8b1r